Used as a key intermediate in the synthesis of benzooxazine compounds, this reagent has significant potential in pharmaceutical research, particularly for developing drugs that act on the central nervous system, such as antiepileptics or anxiolytics. The presence of bromine and carboxylate groups in its structure facilitates further reactions, including nucleophilic substitutions or carbon-carbon bond formations, making it ideal for structural modifications during the development of novel bioactive substances.